Addressing the Challenges of Tuberculosis: A Brief Historical Account

被引：29
作者：
Al-Humadi, Hussam W. [1 ,2 ]
Al-Saigh, Rafal J. [1 ]
Al-Humadi, Ahmed W. [2 ]
机构：
[1] Univ Babylon, Pharm Coll, Dept Pharmacol & Toxicol, Babylon, Iraq
[2] Natl & Kapodistrian Univ Athens, Med Sch, Pharmacol Lab, Athens, Greece
来源：
FRONTIERS IN PHARMACOLOGY | 2017年 / 8卷
关键词：
tuberculosis; history; treatment; anti-TBdrugs; multidrugresistance; pharmaceuticalinnovation; MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE; ANTIRETROVIRAL THERAPY; INFECTION; PYRAZINAMIDE; MECHANISM; BURDEN; CHEMOTHERAPY; STREPTOMYCIN;
D O I：
10.3389/fphar.2017.00689
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Tuberculosis (TB) is a highly contagious disease that still poses a threat to human health. Mycobacterium tuberculosis (MTB), the pathogen responsible for TB, uses diverse ways in order to survive in a variety of host lesions and to subsequently evade immune surveillance; as a result, fighting TB and its associated multidrug resistance has been an ongoing challenge. The aim of this review article is to summarize the historical sequence of drug development and use in the fight against TB, with a particular emphasis on the decades between World War II and the dawn of the twenty first century (2000).
引用
收藏
页数：10
相关论文
共 128 条
[71]  
Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P10
[72]   Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. [J].
Mitnick, C ;
Bayona, J ;
Palacios, E ;
Shin, S ;
Furin, J ;
Alcantara, F ;
Sanchez, E ;
Sarria, M ;
Becerra, M ;
Fawzi, MCS ;
Kapiga, S ;
Neuberg, D ;
Maguire, JH ;
Kim, JY ;
Farmer, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (02) :119-128
[73]   MOLECULAR MECHANISMS OF MULTIPLE-DRUG RESISTANCE IN CLINICAL ISOLATES OF MYCOBACTERIUM-TUBERCULOSIS [J].
MORRIS, S ;
BAI, GH ;
SUFFYS, P ;
PORTILLOGOMEZ, L ;
FAIRCHOK, M ;
ROUSE, D .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :954-960
[74]   Tuberculosis drug resistance: A global threat [J].
Nachega, JB ;
Chaisson, RE .
CLINICAL INFECTIOUS DISEASES, 2003, 36 :S24-S30
[75]   Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against Tuberculosis [J].
Napier, Ruth J. ;
Rafi, Wasiulla ;
Cheruvu, Mani ;
Powell, Kimberly R. ;
Zaunbrecher, M. Analise ;
Bornmann, William ;
Salgame, Padmini ;
Shinnick, Thomas M. ;
Kalman, Daniel .
CELL HOST & MICROBE, 2011, 10 (05) :475-485
[76]   Mycobacterial outer membranes: in search of proteins [J].
Niederweis, Michael ;
Danilchanka, Olga ;
Huff, Jason ;
Hoffmann, Christian ;
Engelhardt, Harald .
TRENDS IN MICROBIOLOGY, 2010, 18 (03) :109-116
[77]  
Nobel Foundation, 2014, NOB PRIZ PHYS MED 19
[78]  
O'Brien R J, 1994, Semin Respir Infect, V9, P104
[79]   The Mycobacterium tuberculosis Secreted Protein Rv0203 Transfers Heme to Membrane Proteins MmpL3 and MmpL11 [J].
Owens, Cedric P. ;
Chim, Nicholas ;
Graves, Amanda B. ;
Harmston, Christine A. ;
Iniguez, Angelina ;
Contreras, Heidi ;
Liptak, Matthew D. ;
Goulding, Celia W. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (30) :21714-21728
[80]  
Patel D.M., 2012, Int. J. Drug Dev. Res, V4, P76
3456789101112